1. Home
  2. RXST vs ZD Comparison

RXST vs ZD Comparison

Compare RXST & ZD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXST
  • ZD
  • Stock Information
  • Founded
  • RXST 1997
  • ZD 1995
  • Country
  • RXST United States
  • ZD United States
  • Employees
  • RXST N/A
  • ZD N/A
  • Industry
  • RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ZD Advertising
  • Sector
  • RXST Health Care
  • ZD Consumer Discretionary
  • Exchange
  • RXST Nasdaq
  • ZD Nasdaq
  • Market Cap
  • RXST 2.0B
  • ZD N/A
  • IPO Year
  • RXST 2021
  • ZD 1999
  • Fundamental
  • Price
  • RXST $34.55
  • ZD $54.78
  • Analyst Decision
  • RXST Strong Buy
  • ZD Buy
  • Analyst Count
  • RXST 8
  • ZD 8
  • Target Price
  • RXST $59.00
  • ZD $70.50
  • AVG Volume (30 Days)
  • RXST 862.4K
  • ZD 474.0K
  • Earning Date
  • RXST 02-26-2025
  • ZD 02-19-2025
  • Dividend Yield
  • RXST N/A
  • ZD N/A
  • EPS Growth
  • RXST N/A
  • ZD 41.38
  • EPS
  • RXST N/A
  • ZD 1.38
  • Revenue
  • RXST $128,293,000.00
  • ZD $1,378,750,000.00
  • Revenue This Year
  • RXST $60.30
  • ZD $6.74
  • Revenue Next Year
  • RXST $34.32
  • ZD $5.56
  • P/E Ratio
  • RXST N/A
  • ZD $39.75
  • Revenue Growth
  • RXST 67.52
  • ZD 0.58
  • 52 Week Low
  • RXST $33.03
  • ZD $37.76
  • 52 Week High
  • RXST $66.54
  • ZD $70.90
  • Technical
  • Relative Strength Index (RSI)
  • RXST 33.96
  • ZD 43.15
  • Support Level
  • RXST $33.03
  • ZD $53.62
  • Resistance Level
  • RXST $35.32
  • ZD $56.97
  • Average True Range (ATR)
  • RXST 1.61
  • ZD 1.87
  • MACD
  • RXST 0.04
  • ZD -0.55
  • Stochastic Oscillator
  • RXST 23.97
  • ZD 18.53

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

Share on Social Networks: